Chorom Pak, PhD
Founder & CEO, LynxBio, Madison, WI
Advisor: Dr. Shigeki Miyamoto
Graduation: 12/2013
Research Interest: Investigation of multiple myeloma heterogeneity through cross-disciplinary approaches
Biography
Alumni News
- Chorom is currently a Biologist at Cellectar Biosciences, Inc.
- Chorom was a joint post-doc with Dr. David Beebe, Dr. Josh Lang, and Dr. Jamey Weichert at UW–Madison (February 2014- 2015)
- 2009 to present: Instructor at the Princeton Review in Madison, WI
- 2008-2013: Graduate research assistant at the UW–Madison with her thesis focused on elucidating the role of the proteasome-inhibitor resistant (PIR) NF-κB pathway in multiple myeloma (MM) drug resistance.
Publications
- Pak C, Young E, Miyamoti S, Beebe D, Callander N, Yang D, and Kahl D (2012). Microscale functional cytomics for studying hematologic cancers. Blood.